Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 717

Results For "RI"

11152 News Found

Dr. Agarwals Eye Hospital posts Q3 FY24 PAT at Rs. 9.44 Cr
Healthcare | January 18, 2024

Dr. Agarwals Eye Hospital posts Q3 FY24 PAT at Rs. 9.44 Cr

The company has posted net profit of Rs.33.57 crores for the 9 Months period ended December 31, 2023


Torque Pharma reinvents healthcare dynamics with 'Better Together'
News | January 18, 2024

Torque Pharma reinvents healthcare dynamics with 'Better Together'

The bold, dynamic, and new logo unveiled in this process captures the essence of the 'Better Together' theme


Indoco Remedies receives EIR from USFDA for Goa Plant-I
Drug Approval | January 18, 2024

Indoco Remedies receives EIR from USFDA for Goa Plant-I

The PAI was conducted for two drug product applications (ANDAs) filed from this facility


Piramal Pharma launches new concentration of Zinc Sulfate for Injection in U.S.
News | January 17, 2024

Piramal Pharma launches new concentration of Zinc Sulfate for Injection in U.S.

The launch will enable PCC to further expand their existing Zinc Sulfate Injection product line and overall the generic injectables portfolio


Parexel collaborates with Japanese Foundation for cancer research
News | January 17, 2024

Parexel collaborates with Japanese Foundation for cancer research

Collaboration streamlines patient access to oncology clinical trials


Alkem Labs reports 'fraudulent transfer' of Rs 52 Cr
Digitisation | January 17, 2024

Alkem Labs reports 'fraudulent transfer' of Rs 52 Cr

The company disclosed that several employees of a subsidiary had their business email addresses stolen


Agilent announces new ProteoAnalyzer system
News | January 17, 2024

Agilent announces new ProteoAnalyzer system

Automated parallel capillary electrophoresis system simplifies protein analysis


Nucala approved in China for use in severe asthma with an eosinophilic phenotype
News | January 16, 2024

Nucala approved in China for use in severe asthma with an eosinophilic phenotype

Approval based on a separate phase III trial among Chinese patients reinforcing mepolizumab’s efficacy and safety data


Nethradhama’s conference on ophthalmology sees launch of advanced eye care technologies
News | January 16, 2024

Nethradhama’s conference on ophthalmology sees launch of advanced eye care technologies

The three-day event in Bengaluru was conducted in collaboration with the Karnataka Ophthalmology Society (KOS) and the Bangalore Ophthalmology Society (BOS)